These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25239454)

  • 1. TRAP1 is involved in BRAF regulation and downstream attenuation of ERK phosphorylation and cell-cycle progression: a novel target for BRAF-mutated colorectal tumors.
    Condelli V; Piscazzi A; Sisinni L; Matassa DS; Maddalena F; Lettini G; Simeon V; Palladino G; Amoroso MR; Trino S; Esposito F; Landriscina M
    Cancer Res; 2014 Nov; 74(22):6693-704. PubMed ID: 25239454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.
    Condelli V; Maddalena F; Sisinni L; Lettini G; Matassa DS; Piscazzi A; Palladino G; Amoroso MR; Esposito F; Landriscina M
    Oncotarget; 2015 Sep; 6(26):22298-309. PubMed ID: 26084290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination.
    Sisinni L; Maddalena F; Condelli V; Pannone G; Simeon V; Li Bergolis V; Lopes E; Piscazzi A; Matassa DS; Mazzoccoli C; Nozza F; Lettini G; Amoroso MR; Bufo P; Esposito F; Landriscina M
    J Pathol; 2017 Sep; 243(1):123-134. PubMed ID: 28678347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAP1 regulates cell cycle and apoptosis in thyroid carcinoma cells.
    Palladino G; Notarangelo T; Pannone G; Piscazzi A; Lamacchia O; Sisinni L; Spagnoletti G; Toti P; Santoro A; Storto G; Bufo P; Cignarelli M; Esposito F; Landriscina M
    Endocr Relat Cancer; 2016 Sep; 23(9):699-709. PubMed ID: 27422900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAP1 regulates stemness through Wnt/β-catenin pathway in human colorectal carcinoma.
    Lettini G; Sisinni L; Condelli V; Matassa DS; Simeon V; Maddalena F; Gemei M; Lopes E; Vita G; Del Vecchio L; Esposito F; Landriscina M
    Cell Death Differ; 2016 Nov; 23(11):1792-1803. PubMed ID: 27662365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922.
    Wang CY; Guo ST; Wang JY; Yan XG; Farrelly M; Zhang YY; Liu F; Yari H; La T; Lei FX; Jin L; Zhang XD; Jiang CC
    Oncotarget; 2016 Aug; 7(31):49597-49610. PubMed ID: 27391062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.
    Preto A; Figueiredo J; Velho S; Ribeiro AS; Soares P; Oliveira C; Seruca R
    J Pathol; 2008 Feb; 214(3):320-7. PubMed ID: 18098337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAP1 enhances Warburg metabolism through modulation of PFK1 expression/activity and favors resistance to EGFR inhibitors in human colorectal carcinomas.
    Maddalena F; Condelli V; Matassa DS; Pacelli C; Scrima R; Lettini G; Li Bergolis V; Pietrafesa M; Crispo F; Piscazzi A; Storto G; Capitanio N; Esposito F; Landriscina M
    Mol Oncol; 2020 Dec; 14(12):3030-3047. PubMed ID: 33025742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAP1-dependent regulation of p70S6K is involved in the attenuation of protein synthesis and cell migration: relevance in human colorectal tumors.
    Matassa DS; Agliarulo I; Amoroso MR; Maddalena F; Sepe L; Ferrari MC; Sagar V; D'Amico S; Loreni F; Paolella G; Landriscina M; Esposito F
    Mol Oncol; 2014 Dec; 8(8):1482-94. PubMed ID: 24962791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells.
    Costantino E; Maddalena F; Calise S; Piscazzi A; Tirino V; Fersini A; Ambrosi A; Neri V; Esposito F; Landriscina M
    Cancer Lett; 2009 Jun; 279(1):39-46. PubMed ID: 19217207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.
    Tian X; Ma P; Sui CG; Meng FD; Li Y; Fu LY; Jiang T; Wang Y; Jiang YH
    FEBS J; 2014 Jun; 281(12):2805-19. PubMed ID: 24754231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins.
    Friday BB; Yu C; Dy GK; Smith PD; Wang L; Thibodeau SN; Adjei AA
    Cancer Res; 2008 Aug; 68(15):6145-53. PubMed ID: 18676837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational control in the stress adaptive response of cancer cells: a novel role for the heat shock protein TRAP1.
    Matassa DS; Amoroso MR; Agliarulo I; Maddalena F; Sisinni L; Paladino S; Romano S; Romano MF; Sagar V; Loreni F; Landriscina M; Esposito F
    Cell Death Dis; 2013 Oct; 4(10):e851. PubMed ID: 24113185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo.
    Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA
    Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.
    Maddalena F; Simeon V; Vita G; Bochicchio A; Possidente L; Sisinni L; Lettini G; Condelli V; Matassa DS; Li Bergolis V; Fersini A; Romito S; Aieta M; Ambrosi A; Esposito F; Landriscina M
    Oncotarget; 2017 Mar; 8(13):21229-21240. PubMed ID: 28177905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAP1 controls cell migration of cancer cells in metabolic stress conditions: Correlations with AKT/p70S6K pathways.
    Agliarulo I; Matassa DS; Amoroso MR; Maddalena F; Sisinni L; Sepe L; Ferrari MC; Arzeni D; Avolio R; Paolella G; Landriscina M; Esposito F
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2570-9. PubMed ID: 26071104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
    Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
    Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins.
    Amoroso MR; Matassa DS; Laudiero G; Egorova AV; Polishchuk RS; Maddalena F; Piscazzi A; Paladino S; Sarnataro D; Garbi C; Landriscina M; Esposito F
    Cell Death Differ; 2012 Apr; 19(4):592-604. PubMed ID: 21979464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer.
    Riesco-Eizaguirre G; Rodríguez I; De la Vieja A; Costamagna E; Carrasco N; Nistal M; Santisteban P
    Cancer Res; 2009 Nov; 69(21):8317-25. PubMed ID: 19861538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.